Results 121 to 130 of about 341,590 (292)
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
Annals of the Rheumatic Diseases, 2020 Juvenile dermatomyositis (JDM) is a rare systemic autoimmune vasculopathy characterised by weakness in proximal muscles and pathognomonic skin rashes.1 Clinically, some patients are refractory to any available treatments or became steroids dependent.2 ...
Yuchuan Ding +6 more
semanticscholar +1 more source
Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report [PDF]
, 2014 INTRODUCTION: Dermatomyositis is a chronic inflammatory disorder characterized by muscular and dermatologic symptoms with variable internal organ involvement.
Andreas Brunauer +5 more
core +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 8, Page 1009-1012, August 2025.
Edgar Akuffo‐Addo +4 more
wiley +1 more source
Clinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases
Immunity, Inflammation and Disease, Volume 13, Issue 5, May 2025.ABSTRACT Background Rheumatic diseases are chronic immune‐mediated disorders affecting multiple organ systems and significantly impairing patients' quality of life. Current treatments primarily provide symptomatic relief without offering a cure. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic option due to their ability to ...
Helal F. Hetta +7 more
wiley +1 more source
Statistics in Medicine, Volume 44, Issue 10-12, May 2025.ABSTRACT Electronic health records (EHRs) provide an efficient approach to generating rich longitudinal datasets. However, since patients visit as needed, the assessment times are typically irregular and may be related to the patient's health. Failing to account for this informative assessment process could result in biased estimates of the disease ...
Rose H. Garrett +3 more
wiley +1 more source
Arthritis & Rheumatology, 2020 Juvenile dermatomyositis (DM) is a heterogeneous systemic immune‐mediated vasculopathy. This study was undertaken to 1) identify inflammation/endothelial dysfunction–related biomarker profiles reflecting disease severity at diagnosis, and 2) establish ...
J. Wienke +14 more
semanticscholar +1 more source
A patient with anti-NXP2-positive dermatomyositis and syphilis [PDF]
, 2020 Dermatomyositis is an auto-immune inflammatory myopathy that primarily affects the skin and muscle and can be triggered by exposure to various environmental factors.
Bovenberg, Maria Sarah Sophie +6 more
core
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine [PDF]
, 2012 Introduction: The idiopathic inflammatory myopathies are rare diseases for which data regarding the natural history, response to therapies and factors affecting mortality are needed.
Crofford, Leslie J. +4 more
core +3 more sources
Rituximab in the treatment of inflammatory myopathies: a review [PDF]
, 2017 Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in refractory myositis did not show a significant difference between the two ...
Fasano, S +4 more
core
Sclerotic metaphyseal lines in children and adolescents treated with alendronate [PDF]
, 2010 INTRODUCTION: Bisphosphonates inhibit bone resorption by interfering with the action of osteoclasts. Among the adverse effects, sclerotic lines observed in the metaphysis of long bones have been described as the main imaging finding in pediatric patients.
Barbosa, Cassia Maria Passarelli Lupoli +5 more
core +3 more sources